COMMUNIQUÉS West-GlobeNewswire

Best Probiotics for Men Over 50 - Most Effective Probiotic Supplements for Men's Gut Health, Colon & Digestive System - Biotics 8
21/04/2025
Best probiotics for men 2025: Supplements to improve gut health and digestive system. Glasgow,UK, April 21, 2025 (GLOBE NEWSWIRE) -- In search of the most effective probiotic supplements for men's health ? We are able [...]
Happy Go Leafy Named Best Kratom Brand in On Pattison’s Latest Review
21/04/2025
On Pattison ranks Happy Go Leafy as the best Kratom brand in its latest review. How was the Assessment Done? What’s Next for HGL? Read more details. Miami. Florida, April 21, 2025 (GLOBE NEWSWIRE) -- In a recent [...]
LIPOZEM REVIEWS: How Reliable Is It? Investigation Completed 2025
21/04/2025
ST. PETERSBURG, Fla., April 21, 2025 (GLOBE NEWSWIRE) -- Lipozem is an all-natural dietary supplement that uses only safe and natural components to promote healthy weight loss. With health and wellness taking center [...]
Achieve Life Sciences Announces Cytisinicline Phase 3 ORCA-3 Trial Publication on Smoking Cessation in JAMA Internal Medicine
21/04/2025
ORCA-3 Demonstrated a Significant Increase in Quitting and Reduction in Nicotine Cravings for Cytisinicline-Treated Participants Compared to Placebo Cytisinicline New Drug Application (NDA) Submission to FDA Planned for [...]
Mindpeak and DigitCells Forge Alliance to Advance AI-Powered Digital Pathology Workflows: A Paradigm Shift for Diagnostic Precision and Efficiency
21/04/2025
DigitCells, an innovator at the forefront of comprehensive pathology solutions, and Mindpeak, a pioneering force in artificial intelligence-driven pathology software, today announced a partnership. This strategic [...]
Kham's House From Grief to Grace: One Mother’s Mission to Support Young Cancer Warriors Now Celebrates Three Years of Hope
21/04/2025
Dallas, TX, April 21, 2025 (GLOBE NEWSWIRE) -- Kham’s House announces its 3-year anniversary celebration, unveiling an expanded slate of services for adolescents and young adults (AYAs) facing cancer and life-altering [...]
Hapbee Technologies Launching Highly Anticipated ‘Boosted Signals’ Feature with Upcoming New App Release
21/04/2025
VANCOUVER, British Columbia, April 21, 2025 (GLOBE NEWSWIRE) -- Hapbee Technologies, Inc. (TSXV: HAPB | OTCQB: HAPBF | FSE: HA1), a digital wellness technology company, today announced the upcoming rollout of a [...]
Clearmind Medicine to Host Live Webinar “Gazing Through the Crystal Ball” Featuring Leading Psychedelic Experts
21/04/2025
Vancouver, Canada, April 21, 2025 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on discovery and development of novel [...]
Senti Bio Participates in a Virtual Investor KOL Connect Segment
21/04/2025
Moderated discussion with Stephen Strickland, MD, MSCI, internationally respected leukemia researcher, Director of Leukemia Research for Sarah Cannon Research Institute and Kanya Rajangam, MD, PhD, President, Head of R [...]
PathAI Announces Poster Presentations at the 2025 American Association of Cancer Research Annual Meeting
21/04/2025
BOSTON, April 21, 2025 (GLOBE NEWSWIRE) -- PathAI, a global leader in AI-powered pathology solutions, today announced it will present research from the outputs of PathAI's pathology universal transformer (PLUTO) [...]
Eascra Biotech Receives U.S. National Science Foundation Grant
21/04/2025
R&D funding accelerates the transition from research to impact BOSTON, April 21, 2025 (GLOBE NEWSWIRE) -- Eascra Biotech announced today that they have been awarded a U.S. National Science Foundation (NSF) Small [...]
Vaccinex to Report Promising New Clinical Data Revealing Pepinemab’s Unique Mechanism to Enhance Immunotherapy at Annual Meeting of American Association for Cancer Research (AACR)
21/04/2025
Neoadjuvant treatment with pepinemab appears to induce abundant, mature lymphoid structures that correlate with durable clinical benefit of immunotherapy in patients with metastatic melanoma. Pepinemab, Semaphorin 4D [...]
Enlivex Announces Completion of Enrollment In The Phase II stage Of Its Phase I/II Trial Evaluating Allocetra In Patients With Moderate To Severe Knee Osteoarthritis
21/04/2025
Nes-Ziona, Israel, April 21, 2025 (GLOBE NEWSWIRE) -- Enlivex Therapeutics Ltd. (Nasdaq: ENLV, the “Company”), a clinical-stage macrophage reprogramming immunotherapy company, today announced that the Company completed [...]
AP Bioscience to Present New Preclinical Data at American Association of Cancer Research Annual Meeting
21/04/2025
TAIPEI, Taiwan, April 21, 2025 (GLOBE NEWSWIRE) -- AP Biosciences, a clinical-stage biopharmaceutical company dedicated to transforming cancer therapy through innovative bispecific antibodies, today announced that it [...]
Sofwave’s SUPERB™ Non-Invasive Skin Treatment Technology Receives Regulatory Clearance in Japan Significantly Expanding its Coverage of the APAC Region
21/04/2025
Japan represents third largest non-surgical medical aesthetic market in the world SAN CLEMENTE, Calif., April 21, 2025 (GLOBE NEWSWIRE) -- Sofwave Medical Ltd (“the Company”) (TASE: SOFW), an emerging leader in energy- [...]
IMUNON Announces IMNN-001 Abstract Accepted for Oral Presentation at 2025 ASCO Annual Meeting
21/04/2025
Highly promising survival data from OVATION 2 Study of treatment of newly diagnosed advanced ovarian cancer to be presented Initiation of Phase 3 trial sites underway for pivotal study of IMNN-001 following alignment on [...]
Reflect Scientific Inc. Announces Strategic Market Transition and Substantial Cost Savings
21/04/2025
OREM, Utah, April 21, 2025 (GLOBE NEWSWIRE) -- Reflect Scientific Inc. (symbol: RSCF), a leading innovator in advanced refrigeration and cooling technologies, today announced significant financial improvements resulting [...]
Tempest Receives Orphan Drug Designation from the FDA for TPST-1495 to Treat Patients with FAP
21/04/2025
BRISBANE, Calif., April 21, 2025 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (Nasdaq: TPST), a clinical-stage biotechnology company developing first-in-class 1 targeted and immune-mediated therapeutics to fight [...]
ORYZON Continues to Strengthen its Patent Portfolio for Vafidemstat
21/04/2025
New “Decision to grant” communications in Europe and Japan MADRID and CAMBRIDGE, Mass., April 21, 2025 (GLOBE NEWSWIRE) -- Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a clinical-stage biopharmaceutical company [...]

Pages